These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 28532260

  • 1. [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer.
    Kollberg P, Almquist H, Bläckberg M, Cwikiel M, Gudjonsson S, Lyttkens K, Patschan O, Liedberg F.
    Scand J Urol; 2017 Aug; 51(4):308-313. PubMed ID: 28532260
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    van de Putte EEF, Vegt E, Mertens LS, Bruining A, Hendricksen K, van der Heijden MS, Horenblas S, van Rhijn BWG.
    Int Urol Nephrol; 2017 Sep; 49(9):1585-1591. PubMed ID: 28674853
    [Abstract] [Full Text] [Related]

  • 3. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
    Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Hervé JM, Botto H, Le Stanc E, Lebret T.
    Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381
    [Abstract] [Full Text] [Related]

  • 4. Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma.
    Giannatempo P, Alessi A, Miceli R, Raggi D, Farè E, Nicolai N, Serafini G, Padovano B, Piva L, Biasoni D, Torelli T, Catanzaro M, Stagni S, Maffezzini M, Mariani L, Gianni AM, Sonpavde G, Salvioni R, Necchi A, Crippa F.
    Clin Genitourin Cancer; 2014 Dec; 12(6):433-9. PubMed ID: 24787972
    [Abstract] [Full Text] [Related]

  • 5. Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer?
    Uttam M, Pravin N, Anish B, Nandita K, Arup M.
    Int Braz J Urol; 2016 Dec; 42(2):234-41. PubMed ID: 27256176
    [Abstract] [Full Text] [Related]

  • 6. Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
    Longoni M, Scilipoti P, Re C, Rosiello G, Nocera L, Pellegrino F, Basile G, de Angelis M, Quarta L, Burgio G, Necchi A, Cigliola A, Chiti A, Picchio M, Salonia A, Briganti A, Montorsi F, Moschini M.
    BJU Int; 2024 Oct; 134(4):636-643. PubMed ID: 38621771
    [Abstract] [Full Text] [Related]

  • 7. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P.
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [Abstract] [Full Text] [Related]

  • 8. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 9. Complete metabolic response with [18 F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer.
    Abrahamsson J, Kollberg P, Almquist H, Bläckberg M, Brändstedt J, Lyttkens K, Simoulis A, Sjödahl G, Sörenby A, Trägårdh E, Liedberg F.
    BJU Int; 2022 Feb; 129(2):174-181. PubMed ID: 33626220
    [Abstract] [Full Text] [Related]

  • 10. Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
    Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C.
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [Abstract] [Full Text] [Related]

  • 11. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
    Kollberg P, Almquist H, Bläckberg M, Cronberg C, Garpered S, Gudjonsson S, Kleist J, Lyttkens K, Patschan O, Liedberg F.
    Scand J Urol; 2015 Jun; 49(4):296-301. PubMed ID: 25623843
    [Abstract] [Full Text] [Related]

  • 12. Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy.
    Dason S, Wong NC, Donahue TF, Meier A, Zheng J, Mannelli L, Di Paolo PL, Dean LW, McPherson VA, Rosenberg JE, Bajorin DF, Capeanu M, Dalbagni G, Vargas HA, Bochner BH.
    J Urol; 2020 Aug; 204(2):254-259. PubMed ID: 32134343
    [Abstract] [Full Text] [Related]

  • 13. The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy.
    Mattoli MV, Massaccesi M, Castelluccia A, Scolozzi V, Mantini G, Calcagni ML.
    Radiat Oncol; 2017 Jan 05; 12(1):4. PubMed ID: 28057034
    [Abstract] [Full Text] [Related]

  • 14. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up.
    Vind-Kezunovic S, Bouchelouche K, Ipsen P, Høyer S, Bell C, Bjerggaard Jensen J.
    Eur Urol Focus; 2019 Jan 05; 5(1):90-96. PubMed ID: 28753817
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
    Fitoussi O, Roche JB, Riviere J, Wallerand H, Poulain JE, Gordien P, Galland S, Henriques B, Dupin C, Vincent M, Kuratle T, Saffarini M, Ramos-Pascual S.
    Urol Int; 2023 Jan 05; 107(3):239-245. PubMed ID: 36657430
    [Abstract] [Full Text] [Related]

  • 16. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial.
    Hinsenveld FJ, Noordman BJ, Boormans JL, Voortman J, van Leenders GJLH, van der Pas SL, van Beek SC, Oprea-Lager DE, Vis AN.
    BMC Cancer; 2021 Oct 29; 21(1):1161. PubMed ID: 34715822
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr 29; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma.
    Voskuilen CS, Schweitzer D, Jensen JB, Nielsen AM, Joniau S, Muilwijk T, Necchi A, Azizi M, Spiess PE, Briganti A, Bandini M, Goffin K, Bouchelouche K, van Werkhoven E, Shariat SF, Xylinas E, Azawi NH, Ku JH, Foerster B, van Rhijn BWG, Vegt E, Hendricksen K.
    Eur Urol Oncol; 2020 Feb 29; 3(1):73-79. PubMed ID: 31591037
    [Abstract] [Full Text] [Related]

  • 19. Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response.
    Ghodoussipour S, Xu W, Tran K, Atkinson R, Cho D, Miranda G, Cai J, Bhanvadia S, Schuckman A, Daneshmand S, Djaladat H.
    Urol Oncol; 2021 Feb 29; 39(2):133.e1-133.e8. PubMed ID: 32900621
    [Abstract] [Full Text] [Related]

  • 20. Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer.
    Girard A, Rouanne M, Taconet S, Radulescu C, Neuzillet Y, Girma A, Beaufrere A, Lebret T, Le Stanc E, Grellier JF.
    Eur Radiol; 2019 Aug 29; 29(8):4286-4293. PubMed ID: 30666449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.